Ledger.Open graph →
SEC Form D · filed March 18, 2019

Lantern Pharma Inc

Offering
$6.3M
Sold
$2.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DALLAS, TX
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

David Silberstein · Dallas, TXDirectorPanna Sharma · Dallas, TXExec · DirectorArunkumar Asaithambi · Dallas, TXDirectorJohn Fucci · Dallas, TXDirectorDonald Keyser · Dallas, TXDirectorAlonzo Kelly · Pittsburgh, PAExec · DirectorTekin Mericli · Pittsburgh, PADirectorMike Stubler · Pittsburgh, PADirectorMichael George · Pittsburgh, PADirectorJames Brailean · SOLANA BEACH, CADirectorNick Braun · San Diego, CADirectorBen Zvaifler · San Diego, CADirectorAriel Zvaifler · San Diego, OHExec · DirectorDonald Keyser · Dallas, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗